These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9453495)
41. Renal hemodynamics and the renin-angiotensin system in cirrhosis. Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770 [TBL] [Abstract][Full Text] [Related]
42. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease. Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858 [TBL] [Abstract][Full Text] [Related]
43. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function. Tsai YT; Lin HC; Yang MC; Lee FY; Hou MC; Chen LS; Lee SD J Hepatol; 1995 Dec; 23(6):681-8. PubMed ID: 8750167 [TBL] [Abstract][Full Text] [Related]
44. The effects of treatment with octreotide, diuretics, or both on portal hemodynamics in nonazotemic cirrhotic patients with ascites. Kalambokis G; Economou M; Kosta P; Papadimitriou K; Tsianos EV J Clin Gastroenterol; 2006 Apr; 40(4):342-6. PubMed ID: 16633107 [TBL] [Abstract][Full Text] [Related]
45. [High circulating levels of adrenomedullin and endothelin-1 in obesity associated with arterial hypertension]. Letizia C; Celi M; Cerci S; Scuro L; Delfini E; Subioli S; Caliumi C; D'Erasmo E Ital Heart J Suppl; 2001 Sep; 2(9):1011-5. PubMed ID: 11675821 [TBL] [Abstract][Full Text] [Related]
46. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal. Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261 [TBL] [Abstract][Full Text] [Related]
47. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457 [TBL] [Abstract][Full Text] [Related]
48. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites. Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171 [TBL] [Abstract][Full Text] [Related]
49. Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gentilini P; Romanelli RG; La Villa G; Maggiore Q; Pesciullesi E; Cappelli G; Casini Raggi V; Foschi M; Marra F; Pinzani M Gastroenterology; 1993 Feb; 104(2):588-94. PubMed ID: 8425702 [TBL] [Abstract][Full Text] [Related]
50. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis. Uchihara M; Izumi N; Sato C; Marumo F Hepatology; 1992 Jul; 16(1):95-9. PubMed ID: 1535610 [TBL] [Abstract][Full Text] [Related]
51. Time course of endothelin-1 and adrenomedullin after the Fontan procedure. Hiramatsu T; Imai Y; Takanashi Y; Seo K; Terada M; Aoki M; Nakazawa M Ann Thorac Surg; 1999 Jul; 68(1):169-72. PubMed ID: 10421135 [TBL] [Abstract][Full Text] [Related]
52. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Cassinello C; Moreno E; Gozalo A; Ortuño B; Cuenca B; Solís-Herruzo JA Dig Dis Sci; 2003 Jan; 48(1):179-86. PubMed ID: 12645807 [TBL] [Abstract][Full Text] [Related]
53. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Cheung B; Leung R Clin Sci (Lond); 1997 Jan; 92(1):59-62. PubMed ID: 9038592 [TBL] [Abstract][Full Text] [Related]
54. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites. Rivolta R; Maggi A; Cazzaniga M; Castagnone D; Panzeri A; Solenghi D; Lorenzano E; di Palo FQ; Salerno F Hepatology; 1998 Nov; 28(5):1235-40. PubMed ID: 9794906 [TBL] [Abstract][Full Text] [Related]
55. [Renal tubular function in cirrhotic patients with ascites: special reference to lithium clearance following the human atrial natriuretic peptide administration]. Ando M Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):791-801. PubMed ID: 1837568 [TBL] [Abstract][Full Text] [Related]
56. Plasma endothelin-1 levels in liver cirrhosis. Bruno CM; Neri S; Sciacca C; Caruso L Int J Clin Lab Res; 2000; 30(4):169-72. PubMed ID: 11289706 [TBL] [Abstract][Full Text] [Related]
57. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume. Saló J; Francitorra A; Follo A; Navasa M; Ginès A; Jiménez W; Ginès P; Arroyo V; Rivera F; Rodés J J Hepatol; 1995 Apr; 22(4):389-98. PubMed ID: 7665857 [TBL] [Abstract][Full Text] [Related]
58. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites. Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940 [TBL] [Abstract][Full Text] [Related]
59. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis. Lieberman FL; Ito S; Reynolds TB J Clin Invest; 1969 Jun; 48(6):975-81. PubMed ID: 5771197 [TBL] [Abstract][Full Text] [Related]